Brief: Centessa Pharmaceuticals Reports Financial Results For The Fourth Quarter And Full-Year 2022

Centessa Pharmaceuticals

30/03/2023 12:27

March 30 (Reuters) - Centessa Pharmaceuticals Plc
 260Y.F :
    * CENTESSA PHARMACEUTICALS REPORTS RECENT BUSINESS PROGRESS
AND
FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL-YEAR 2022
    * CASH RUNWAY INTO 2026
    * QTRLY NET LOSS PER ORDINARY SHARE, BASIC AND DILUTED $0.45
    * CASH AND CASH EQUIVALENTS $393.6 MILLION AS OF DECEMBER
31,
2022, WHICH COMPANY EXPECTS WILL FUND OPERATIONS INTO 2026
    * Q4 EARNINGS PER SHARE VIEW $-0.48 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX9Sl4sW 
Further company coverage:  260Y.F 

 ((Reuters.Briefs@thomsonreuters.com;))